carbostyril has been researched along with Campylobacter Infection in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (12.82) | 18.2507 |
| 2000's | 16 (41.03) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 6 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Berrang, ME; Cox, NA; Hinton, A; Plumblee Lawrence, JR; Thompson, TM; Yeh, HY | 1 |
| Bort, B; Iranzo, M; Martí, P; Mormeneo, M; Mormeneo, S | 1 |
| Carson, CA; Gibbens, K; Isada, MJ; MacKinnon, MC; Parmley, EJ; Reist, M; Uhland, FC; Young, KM | 1 |
| Abay, S; Aydin, F; Hizlisoy, H; Karakaya, E; Kayman, T; Sahin, O; Saticioğlu, İB | 1 |
| Boqvist, S; Emanuelson, U; Fernström, LL; Frosth, S; Hansson, I; Tamminen, LM | 1 |
| Cernicchiaro, N; Keil, DJ; Nagaraja, TG; Nickell, JS; Renter, DG; Shi, X; Smith, AB | 1 |
| Aleshkina, AI; Bykova, IV; Efimochkina, NR; Markova, YM; Polyanina, AS; Sheveleva, SA; Stetsenko, VV | 1 |
| Cernicchiaro, N; Nagaraja, TG; Renter, DG; Sahin, O; Shi, X; Smith, AB | 1 |
| Essig, A; Grüner, B; Hagemann, JB; Haverkamp, S; Kuchenbauer, F | 1 |
| Abbasi, E; Ghaznavi-Rad, E; van Belkum, A | 1 |
| Abad-Moreno, JC; Echeita, MA; García-Peña, FJ; Herrera-León, S; Pérez-Boto, D | 1 |
| Jonas, R; Kittl, S; Kuhnert, P; Overesch, G | 1 |
| Häkkinen, L; Hänninen, ML; Hörman, A; Ivanova, M; Kovalenko, K; Kramarenko, T; Lillenberg, M; Mäesaar, M; Meremäe, K; Roasto, M; Sõgel, J | 1 |
| Borge, C; Campos, MJ; Domínguez, L; Hormeño, L; Palomo, G; Píriz, S; Porrero, MC; Quesada, A; Ugarte-Ruiz, M; Vadillo, S | 1 |
| AbdelRahman, MA; Hamed, EA; Morsy, MM; Nasef, SA; Shalaby, AG | 1 |
| Bakeli, G; Chida, T; Kumita, W; Okamura, N; Ono, E; Saito, R; Sato, K | 1 |
| Evans, MR; Hopkins, AL; Northey, G; Rigby, CJ; Sarvotham, TS; Thomas, DR | 1 |
| Ahmed, SF; El-Beih, FM; El-Mohamady, H; Ismail, TF; Klena, JD; Monteville, MR; Rockabrand, DM; Said, MM; Salama, MS | 1 |
| Abad-Moreno, JC; Echeita, MA; García-Peña, FJ; Pérez-Boto, D | 1 |
| Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q | 1 |
| Avrain, L; Humbert, F; Kempf, I; L'Hospitalier, R; Sanders, P; Vernozy-Rozand, C | 1 |
| Bartelt, E; Beckmann, L; Klein, G; Luber, P; Müller, M; Schrader, C | 1 |
| Hogan, T; McIver, C; Tapsall, J; White, P | 1 |
| Ishihara, K; Kijima-Tanaka, M; Kira, T; Kojima, A; Morioka, A; Ogikubo, K; Takahashi, T; Tamura, Y | 1 |
| Blaser, MJ; Iovine, NM | 1 |
| Asai, Y; Itoh, K; Niwa, H; Yamai, S | 1 |
| Helms, M; Mølbak, K; Olsen, KE; Simonsen, J | 1 |
| Boonmar, S; Morita, Y; Padungtod, P; Sangsuk, L; Suthivarakom, K | 1 |
| Chaniotaki, S; Chatzipanagiotou, S; Ioannidis, A; Ioannidou, V; Legakis, NJ; Nicolaou, C; Papavasileiou, E; Tzouvelekis, L; Vatopoulos, A | 1 |
| Ellis-Pegler, RB; Hyman, LK; Ingram, RJ; McCarthy, M | 1 |
| Huysmans, MB; Turnidge, JD | 1 |
| Gallardo, F; Goñi, P; Jimenez De Anta, T; Marco, F; Mirelis, B; Ruiz, J; Vila, J | 1 |
| Ellis-Pegler, RB; Voss, LM | 1 |
| Anstead, G; Blaser, M; Craig, F; Jorgensen, J; Patterson, T | 1 |
| Lau, SK; Leung, KW; Woo, PC; Yuen, KY | 1 |
| Evans, TG; Riley, D | 1 |
| Catalán, S; Chaves, F; de Rafael, L; Dronda, F | 1 |
2 review(s) available for carbostyril and Campylobacter Infection
| Article | Year |
|---|---|
Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Canada; Cost of Illness; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Quinolones | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
3 trial(s) available for carbostyril and Campylobacter Infection
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
A Randomized Trial to Assess the Effect of Fluoroquinolone Metaphylaxis on the Fecal Prevalence and Quinolone Susceptibilities of Salmonella and Campylobacter in Feedlot Cattle.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Feces; Fluoroquinolones; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Prevalence; Quinolones; Random Allocation; Salmonella enterica; Salmonella Infections, Animal | 2017 |
A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community.
Topics: Adult; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Community-Acquired Infections; Diarrhea; Double-Blind Method; Drug Resistance, Microbial; Feces; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Quinolones | 1995 |
35 other study(ies) available for carbostyril and Campylobacter Infection
| Article | Year |
|---|---|
Prevalence and Characterization of Quinolone Resistance in Campylobacter spp. Isolates in Chicken Livers from Retail Stores in Georgia, USA.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Double-Blind Method; Drug Resistance, Bacterial; Georgia; Liver; Microbial Sensitivity Tests; Prevalence; Quinolones | 2022 |
Prevalence and Antimicrobial Resistance of
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Prevalence; Quinolones; Spain; Tetracyclines | 2022 |
MLST genotypes and quinolone resistance profiles of Campylobacter jejuni isolates from various sources in Turkey.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Dogs; Drug Resistance, Bacterial; Genotype; Humans; Multilocus Sequence Typing; Quinolones | 2023 |
Occurrence of Campylobacter spp. in Swedish calves, common sequence types and antibiotic resistance patterns.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Cattle; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones; Sweden; Whole Genome Sequencing | 2021 |
Studying the Phenotypic and Genotypic Expression of Antibiotic Resistance in Campylobacter jejuni under Stress Conditions.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Campylobacter Infections; Campylobacter jejuni; Chickens; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genotype; Meat Products; Microbial Sensitivity Tests; Phenotype; Quinolones; Tetracyclines | 2018 |
Campylobacter Prevalence and Quinolone Susceptibility in Feces of Preharvest Feedlot Cattle Exposed to Enrofloxacin for the Treatment of Bovine Respiratory Disease.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cattle Diseases; Cross-Sectional Studies; Drug Resistance, Bacterial; Enrofloxacin; Kansas; Prevalence; Quinolones; Texas | 2018 |
Pulmonary Campylobacter concisus infection in an immunocompromised patient with underlying mucormycosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Campylobacter; Campylobacter Infections; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lung Abscess; Macrolides; Male; Mucormycosis; Quinolones; Respiratory Tract Infections | 2018 |
Quinolone and Macrolide-Resistant
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Flagellin; Gastroenteritis; Genotype; Humans; Infant; Iran; Macrolides; Male; Microbial Sensitivity Tests; Quinolones; RNA, Ribosomal, 23S; Tetracycline | 2019 |
Molecular mechanisms of quinolone, macrolide, and tetracycline resistance among Campylobacter isolates from initial stages of broiler production.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Campylobacter; Campylobacter Infections; Chickens; Drug Resistance, Multiple, Bacterial; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Plasmids; Polymorphism, Restriction Fragment Length; Poultry Diseases; Quinolones; Sequence Analysis, DNA; Spain; Tetracycline | 2014 |
Genotypes and antibiotic resistance of bovine Campylobacter and their contribution to human campylobacteriosis.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Cattle Diseases; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Flagellin; Gastroenteritis; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; Multilocus Sequence Typing; Quinolones; RNA, Ribosomal, 23S | 2015 |
Antimicrobial Resistance Profiles of Campylobacter spp. Isolated from Broiler Chicken Meat of Estonian, Latvian and Lithuanian Origin at Estonian Retail Level and from Patients with Severe Enteric Infections in Estonia.
Topics: Animals; Anti-Bacterial Agents; Baltic States; Campylobacter; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; Drug Resistance, Multiple, Bacterial; Food Contamination; Food Microbiology; Humans; Meat; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones | 2016 |
Identification of the main quinolone resistance determinant in Campylobacter jejuni and Campylobacter coli by MAMA-DEG PCR.
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Molecular Sequence Data; Phenotype; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Public Health Surveillance; Quinolones; Sequence Alignment; Spain | 2016 |
Antibiotic resistance and polymorphism in the quinolone resistance-determining region of Campylobacter spp. isolated from 1-day-old ducklings.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Base Sequence; Campylobacter; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; DNA Gyrase; Drug Resistance, Bacterial; Ducks; Egypt; Phylogeny; Polymorphism, Genetic; Poultry Diseases; Quinolones | 2016 |
Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Diarrhea; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Feces; Humans; Microbial Sensitivity Tests; Quinolones; Tokyo | 2008 |
Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Gastroenteritis; Humans; Infant; Interviews as Topic; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Treatment Outcome; Wales; Young Adult | 2009 |
Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child, Preschool; DNA Gyrase; Drug Resistance, Bacterial; Egypt; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; Quinolones | 2010 |
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Macrolides; Microbial Sensitivity Tests; Poultry Diseases; Quinolones; Spain; Tetracyclines | 2013 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2003 |
Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Poultry Diseases; Quinolones; Tetracycline | 2003 |
Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
Topics: Animals; Base Sequence; Campylobacter Infections; Campylobacter jejuni; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Food Microbiology; Genes, Bacterial; Humans; Mutation; Mutation, Missense; Nalidixic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Poultry; Quinolones | 2004 |
Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
Topics: Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones | 2004 |
Antimicrobial susceptibilities of Campylobacter isolated from food-producing animals on farms (1999-2001): results from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.
Topics: Aminoglycosides; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Dihydrostreptomycin Sulfate; Drug Resistance, Bacterial; Fluoroquinolones; Japan; Macrolides; Microbial Sensitivity Tests; Oxytetracycline; Quinolones; Swine; Tetracycline Resistance | 2004 |
Antimicrobial resistance in Campylobacter.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Poultry Diseases; Quinolones | 2004 |
Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolates in Japan.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Food Microbiology; Humans; Meat; Poultry Products; Quinolones; Treatment Outcome | 2004 |
Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cohort Studies; Denmark; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Risk Factors; Virulence | 2005 |
Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand.
Topics: Animals; Campylobacter Infections; Campylobacter jejuni; Disease Susceptibility; Drug Resistance, Bacterial; Humans; Poultry; Poultry Products; Quinolones; Thailand | 2005 |
Absence of the plasmid-mediated quinolone resistance qnrA gene among Campylobacter jejuni clinical isolates from Greece.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Greece; Humans; Plasmids; Quinolones | 2005 |
Disc susceptibility testing for thermomphilic campylobacters.
Topics: Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chloramphenicol; Gentamicins; Humans; Lactams; Macrolides; Microbial Sensitivity Tests; Quinolones; Tetracycline | 1997 |
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates.
Topics: Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Diarrhea; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Feces; Humans; Mutation; Quinolones; Spain | 1998 |
Patients with infectious gastroenteritis in New Zealand rarely need antimicrobial treatment.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Drug Resistance, Microbial; Escherichia coli Infections; Fluoroquinolones; Gastroenteritis; Humans; New Zealand; Practice Patterns, Physicians'; Quinolones; Salmonella Infections | 2000 |
FDA hastening withdrawal of fluoroquinolone approvals for poultry.
Topics: Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Drug Approval; Enrofloxacin; Fluoroquinolones; Quinolones; Risk Assessment; Turkeys; United States; United States Food and Drug Administration | 2000 |
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ceftazidime; Cephalosporins; Diarrhea; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Histiocytes; Histiocytosis; Humans; Hypersplenism; Male; Penicillanic Acid; Penicillins; Phagocytosis; Piperacillin; Quinolones; Splenic Infarction; Splenomegaly; Tazobactam | 2001 |
Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients.
Topics: Adolescent; Bone Marrow Transplantation; Campylobacter Infections; Campylobacter jejuni; Cohort Studies; Drug Resistance, Multiple; Female; Hong Kong; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Quinolones; Sensitivity and Specificity; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone.
Topics: Adult; Campylobacter Infections; Colitis; Female; HIV Infections; Humans; Quinolones | 1992 |
[Acute Campylobacter jejuni enterocolitis resistant to quinolones in an HIV-positive patient].
Topics: Adult; Campylobacter Infections; Campylobacter jejuni; Drug Resistance, Microbial; Enterocolitis; HIV Infections; Humans; Male; Quinolones | 1992 |